Acrivon Therapeutics, Inc. ACRV

Institutional shares held 22.6 Million

0 calls

0 puts

Total value of holdings $0

$0 calls

$0 puts

Market Cap N/A

Institutional ownership N/A

# of Institutions 56

We take great care to ensure that the data presented and summarized in this overview for Acrivon Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.

Quarterly Institutional Activity in ACRV

Shares Bought

Shares Sold

View Transactions

Top Institutions Holding ACRV

View all

Latest Institutional Activity in ACRV

Top Purchases

Q2 2025

Ground Swell Capital, LLC Shares Held: 12.2K ($0)

12.2K Shares purchased

New Holding

Q2 2025

Cwm, LLC Shares Held: 790 ($0)

741 Shares purchased

1512.24% Added

Q2 2025

Mirae Asset Global Investments Co., Ltd. Shares Held: 1.21K ($0)

169 Shares purchased

16.22% Added

Q1 2025

Wellington Management Group LLP Shares Held: 888K ($0)

888K Shares purchased

New Holding

Q1 2025

Wealthedge Investment Advisors, LLC Shares Held: 56.5K ($0)

45.6K Shares purchased

420.1% Added

View All Buyers

Top Sells

Q2 2025

Nisa Investment Advisors, LLC Shares Held: 584 ($0)

375 Shares sold

39.1% Reduced

Q1 2025

Citadel Advisors LLC Shares Held: 1.9M ($0)

224K Shares sold

10.57% Reduced

Q1 2025

Goldman Sachs Group Inc Shares Held: 57.5K ($0)

180K Shares sold

75.79% Reduced

Q1 2025

Marshall Wace, LLP Shares Held: 450K ($0)

147K Shares sold

24.66% Reduced

Q1 2025

Ubs Oconnor LLC Shares Held: 15.6K ($0)

87.2K Shares sold

84.85% Reduced

View All Sellers

About ACRV

Insider Transactions at ACRV

Insider Transaction List

View all

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Aug 01 2025	Adam D. Levy Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	1,164 -8.74%	$1,164 $1.26 P/Share
Jul 17 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	558 -1.54%	$558 $1.32 P/Share
May 21 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Direct	19,904 -0.89%	$19,904 $1.15 P/Share
May 14 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	184 -0.5%	$184 $1.14 P/Share
May 14 2025	Katharine Peterson Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	99 -2.24%	$99 $1.14 P/Share
May 14 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Indirect	491 -0.16%	$491 $1.14 P/Share
May 14 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Direct	59,766 -2.61%	$59,766 $1.14 P/Share
May 14 2025	Eric Devroe Chief Operating Officer	SELL Payment of exercise price or tax liability	Direct	613 -0.91%	$613 $1.14 P/Share
May 14 2025	Erick Gamelin Chief Development Officer	SELL Payment of exercise price or tax liability	Direct	403 -2.44%	$403 $1.14 P/Share
May 01 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	298,886 -8.78%	$298,886 $1.34 P/Share
Apr 30 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	437,881 -11.4%	$437,881 $1.41 P/Share
Apr 29 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	250,000 -6.11%	$250,000 $1.41 P/Share
Apr 28 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	215,283 -5.0%	$215,283 $1.56 P/Share
Apr 25 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	1,054,669 -19.67%	$1,054,669 $1.95 P/Share
Apr 17 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	558 -1.51%	$558 $1.81 P/Share
Feb 21 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Direct	19,904 -0.86%	$99,520 $5.54 P/Share
Feb 14 2025	Katharine Peterson Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	116 -2.56%	$580 $5.42 P/Share
Feb 14 2025	Rasmus Holm Jorgensen Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	434 -1.64%	$2,170 $5.42 P/Share
Feb 14 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	217 -0.58%	$1,085 $5.42 P/Share
Feb 14 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Indirect	579 -0.18%	$2,895 $5.42 P/Share

View All Transactions

Last 12 Months Summary

Buy / Acquisition

0 Shares

From 0 Insiders

Sell / Disposition

2.62M Shares

From 9 Insiders

Open market or private sale	2.26M shares
Payment of exercise price or tax liability	368K shares

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Insider Trading

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Acrivon Therapeutics, Inc.

Track Activities on ACRV

Account

Acrivon Therapeutics, Inc. ACRV

Quarterly Institutional Activity in ACRV

Top Institutions Holding ACRV

Latest Institutional Activity in ACRV

Top Purchases

Top Sells

About ACRV

Insider Transactions at ACRV

Insider Transaction List

Last 12 Months Summary

Track Institutional and Insider Activities on ACRV

Institutional Portfolio Updates

Insider Trading

News